Influenza A Virus, H7N9 Subtype Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs Market Report Overview
Avian influenza A (H7N9) is a subtype of influenza viruses. This infection is seen both in humans and birds. Infection is caused when a person is exposure to infected poultry or contaminated environments. Symptoms include fever, cough that produces sputum, headache, myalgia, and general malaise. Treatment includes antiviral drugs.
The Influenza A Virus, H7N9 Subtype Infections pipeline drugs market research report provides comprehensive information on the Influenza A Virus, H7N9 Subtype Infections targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also reviews key players involved in Influenza A Virus, H7N9 Subtype Infections targeted therapeutics development with respective active and dormant or discontinued projects.
Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs Market Segmentation by Target
The key targets in the Influenza A Virus, H7N9 Subtype Infections pipeline drugs market are Hemagglutinin, Exo Alpha Sialidase, Interferon Alpha/Beta Receptor 1, Interferon Alpha/Beta Receptor 2, Neuraminidase A, and Polymerase Basic Protein 2 among others. Hemagglutinin was the target with the highest number of Influenza A Virus, H7N9 Subtype Infections drugs in development in 2022.
Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs Market Analysis, by Target
For more target insights on Influenza A Virus, H7N9 Subtype Infections pipeline drugs market, download a free report sample
Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs Market Segmentation by Mechanisms of Action
The key mechanisms of action of the Influenza A Virus, H7N9 Subtype Infections pipeline drugs market are Exo Alpha Sialidase Inhibitor, Hemagglutinin Inhibitor, Interferon Alpha/Beta Receptor 1 Agonist, Interferon Alpha/Beta Receptor 2 Agonist, and Neuraminidase A Inhibitor among others. Exo Alpha Sialidase Inhibitor and Hemagglutinin Inhibitor led the Influenza A Virus, H7N9 Subtype Infections pipeline drugs market in 2022.
Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs Market Analysis, by Mechanisms of Action
For more MoA insights on the Influenza A Virus, H7N9 Subtype Infections pipeline drugs market, download a free report sample
Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs Market Segmentation by Routes of Administration
The key routes of administration in the Influenza A Virus, H7N9 Subtype Infections pipeline drugs market are intramuscular, oral, parenteral, inhalational, intralesional, intravenous, and nasal. Intramuscular and oral are the most preferred RoA in the Influenza A Virus, H7N9 Subtype Infections pipeline drugs market.
Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs Market Analysis, by Routes of Administration
For more RoA insights on the Influenza A Virus, H7N9 Subtype Infections pipeline drugs market, download a free report sample
Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs Market Segmentation by Molecule Types
The key molecule types in the Influenza A Virus, H7N9 Subtype Infections pipeline drugs market are small molecule, inactivated vaccine, vaccine, DNA vaccine, recombinant protein, and subunit vaccine among others. Small molecule leads the pipeline drugs market in this segment.
Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs Market Analysis, by Molecule Types
To know more about molecule types in the Influenza A Virus, H7N9 Subtype Infections pipeline drugs market, download a free report sample
Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs Market - Competitive Landscape
Some of the leading companies in the Influenza A Virus, H7N9 Subtype Infections pipeline drugs market are NanoViricides Inc, TaiGen Biotechnology Co Ltd, AIM ImmunoTech Inc, AusBio Ltd, Beijing Tiantan Biological Products Co Ltd, Celdara Medical LLC, and Cocrystal Pharma Inc among others.
Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs Market Analysis, by Companies
To know more about leading Influenza A Virus, H7N9 Subtype Infections pipeline drugs market players, download a free report sample
Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs Market Overview
Key Target | Hemagglutinin, Exo Alpha Sialidase, Interferon Alpha/Beta Receptor 1, Interferon Alpha/Beta Receptor 2, Neuraminidase A, and Polymerase Basic Protein 2 |
Key Mechanisms of Action | Exo Alpha Sialidase Inhibitor, Hemagglutinin Inhibitor, Interferon Alpha/Beta Receptor 1 Agonist, Interferon Alpha/Beta Receptor 2 Agonist, and Neuraminidase A Inhibitor |
Key Routes of Administration | Intramuscular, Oral, Parenteral, Inhalational, Intralesional, Intravenous, and Nasal |
Key Molecule Types | Small Molecule, Inactivated Vaccine, Vaccine, DNA Vaccine, Recombinant Protein, and Subunit Vaccine |
Leading Companies | NanoViricides Inc, TaiGen Biotechnology Co Ltd, AIM ImmunoTech Inc, AusBio Ltd, Beijing Tiantan Biological Products Co Ltd, Celdara Medical LLC, and Cocrystal Pharma Inc |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Influenza A Virus, H7N9 Subtype Infections (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Influenza A Virus, H7N9 Subtype Infections (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Influenza A Virus, H7N9 Subtype Infections (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Influenza A Virus, H7N9 Subtype Infections (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Influenza A Virus, H7N9 Subtype Infections (Infectious Disease)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Influenza A Virus, H7N9 Subtype Infections (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Influenza A Virus, H7N9 Subtype Infections (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
AusBio Ltd
Beijing Tiantan Biological Products Co Ltd
Celdara Medical LLC
Cocrystal Pharma Inc
Codagenix Inc
CSL Ltd
EpiVax Inc
Greffex Inc
GSK plc
Hualan Biological Bacterin Co Ltd
Inovio Pharmaceuticals Inc
Medicago Inc
NanoViricides Inc
New Amsterdam Sciences Inc
Ology Bioservices Inc
Pneumagen Ltd
TaiGen Biotechnology Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key target areas in the Influenza A Virus, H7N9 Subtype Infections pipeline drugs market?
The key targets in the Influenza A Virus, H7N9 Subtype Infections pipeline drugs market are Hemagglutinin, Exo Alpha Sialidase, Interferon Alpha/Beta Receptor 1, Interferon Alpha/Beta Receptor 2, Neuraminidase A, and Polymerase Basic Protein 2 among others.
-
What are the key mechanisms of action in the Influenza A Virus, H7N9 Subtype Infections pipeline drugs market?
The key MoA in the Influenza A Virus, H7N9 Subtype Infections pipeline drugs market are Exo Alpha Sialidase Inhibitor, Hemagglutinin Inhibitor, Interferon Alpha/Beta Receptor 1 Agonist, Interferon Alpha/Beta Receptor 2 Agonist, and Neuraminidase A Inhibitor.
-
What are the key routes of administration in the Influenza A Virus, H7N9 Subtype Infections pipeline drugs market?
The key RoA in the Influenza A Virus, H7N9 Subtype Infections pipeline drugs market are intramuscular, oral, parenteral, inhalational, intralesional, intravenous, and nasal.
-
What are the key molecule types in the Influenza A Virus, H7N9 Subtype Infections pipeline drugs market?
The key molecule types in the Influenza A Virus, H7N9 Subtype Infections pipeline drugs market are small molecule, inactivated vaccine, vaccine, DNA vaccine, recombinant protein, and subunit vaccine among others.
-
Which are the leading companies in the Influenza A Virus, H7N9 Subtype Infections pipeline drugs market?
Some of the leading companies in the Influenza A Virus, H7N9 Subtype Infections pipeline drugs market are NanoViricides Inc, TaiGen Biotechnology Co Ltd, AIM ImmunoTech Inc, AusBio Ltd, Beijing Tiantan Biological Products Co Ltd, Celdara Medical LLC, and Cocrystal Pharma Inc among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.